Genetic studies in isolated populations have provided increased power for identifying loci associated with complex diseases and traits. We present here the Kibbutzim Family Study (KFS), initiated for investigating environmental and genetic determinants of cardiometabolic traits in extended Israeli families living in communes characterized by long-term social stability and homogeneous environment. Extensive information on cardiometabolic traits, as well as genome-wide genetic data, was collected on 901 individuals, making this study, to the best of our knowledge, the largest of its kind in Israel. We have thoroughly characterized the KFS genetic structure, observing that most participants were of Ashkenazi Jewish (AJ) origin, and confirming a recent severe bottleneck in their recent history (point estimates: effective size ≈450 individuals, 23 generations ago). Focusing on genetic variants enriched in KFS compared with non-Finnish Europeans, we demonstrated that AJ-specific variants are largely involved in cancer-related pathways. Using linear mixed models, we conducted an association study of these enriched variants with 16 cardiometabolic traits. We found 24 variants to be significantly associated with cardiometabolic traits. The strongest association, which we also replicated, was between a variant upstream of the MSRA gene, ≈200-fold enriched in KFS, and weight (P=3.6•10 -8 ). In summary, the KFS is a valuable resource for the study of the population genetics of Israel as well as the genetics of cardiometabolic traits in a homogeneous environment.
Introduction
From an evolutionary perspective, rare variants are on average more recent than common variants, and are thus more likely to be disease risk factors. Genetic association studies of common diseases and traits in isolated populations were particularly advantageous for identification of risk loci that are rare in the general population, but possibly enriched or common in an isolated population (Trecartin et al. 1981; Baier and L.Hanson 2004; Kristiansson et al. 2008; Sabatti et al. 2009; Zeggini 2014; Nair and Baier 2015; Fang et al. 2016; Gilly et al. 2016; Lopes et al. 2016; Zeggini et al. 2016) . The Ashkenazi Jewish (AJ) population has been an attractive population for genetic studies, because of its unique demographic history of a recent severe bottleneck followed by a rapid expansion and monogamy (Guha et al. 2012) . AJ were found to carry unique mutations responsible for a wide range of Mendelian disorders as well as risk factors for complex diseases (Charrow 2004; Kenny et al. 2012) . Importantly, while these mutations may be unique or nearly-unique to AJ, they often highlight pathways of broad significance.
Cardiovascular disease (CVD) is a common cause of death worldwide (Mathers and Loncar 2006) . Genome-wide association studies (GWAS) in unrelated individuals have identified thousands of genetic variants associated with CVD and numerous related risk factors (Fall and Ingelsson 2014; Atanasovska et al. 2015) , but the risk is not fully explained. The Kibbutzim Family Study (KFS) was established in 1992 to investigate the environmental and genetic basis of cardiometabolic risk factors and their change over time (Friedlander et al. 1995 (Friedlander et al. , 2005 (Friedlander et al. , 2006 ; Lemaitre et al. 2008) . The participants belonged, at the time of recruitment, to large families living in close-knit communities, called "Kibbutzim", in Northern Israel. The Kibbutz has been a communal settlement, which has created a relatively homogeneous environment for its members. For example, earnings were uniformly distributed, and Kibbutz members typically dined jointly. Kibbutz members are mostly of Ashkenazi Jewish ancestry, with the remaining members belonging to other Jewish subgroups. The KFS is thus expected to be a useful resource for the study of cardiometabolic genetic risk factors.
While most association studies so far were conducted on unrelated individuals, the extended family design of the KFS has the advantages of reduced sensitivity to population stratification bias and the ability to detect Mendelian inconsistencies (Ott et al. 2011) . Also, as in isolated populations, family-based studies have additional ability to enrich for genetic loci containing rare variants. Familial aggregation, segregation analyses and linkage and candidate gene association studies were previously conducted in KFS (Friedlander et al. 1999a; b, 2003 Sinnreich et al. 1999; Lemaitre et al. 2008) , focusing on outcomes such as LDL peak particle diameter (Friedlander et al. 1999a) , fibrinogen variability (Friedlander et al. 2003) and red blood cell membrane fatty acid composition (Lemaitre et al. 2008) .
Here, we present results for genome-wide genotyping of 901 KFS participants (genotyped at ≈500k variants). We aimed to (1) characterize the population genetics of the KFS population and its relation to other worldwide populations; and (2) assess the contribution of enriched genetic variants in the KFS to the genetic basis of cardiometabolic traits and other healthrelated phenotypes.
Methods

Recruitment strategy
Participants (n=1033) in the KFS were recruited and sampled in two phases in 1992 -1993 and 1999 -2000 (Friedlander et al. 1999a , from six Kibbutzim in Northern Israel (Friedlander et al. 2003) . The first recruitment phase of the study (1992) (1993) included 80 extended families, ranging in size from 2 to 43 individuals (Sinnreich et al. 1998) . During the second phase (1999) (2000) , participants from the first phase were all invited for repeat examinations (80% response rate) and new participants were recruited, giving a total of 150 extended families ranging in size from 2 to 55 individuals (Friedlander et al. 2006) . Families were invited to participate if they consisted of at least four individuals who (i) lived in the Kibbutz, (ii) spanned at least two generations, and (iii) were at least 15 years old. Families were retained if at least two family members consented to participate in the study. Overall, 1033 participants were recruited; 111 were examined only in the first phase, 533 only in the second phase, and 389 were included in both ( Figure 1 ).
Data Collection
All subjects signed an informed consent and completed a self-administered socio-demographic and health questionnaire, including questions on medical and family history, cigarette smoking, alcohol consumption, and physical activity (Sinnreich et al. 1998; Friedlander et al. 2006 ). The participants also signed a set of psychosocial questionnaires, similar to that described by (Kark et al. 1996) , with some differences between the phases. Dietary information was collected using a Food Frequency Questionnaire in the second phase only. Peripheral blood samples (25 ml) were collected at both phases following a 12-hour fast. Anthropometric and blood pressure traits (described below) were measured at both phases (Friedlander et al. 1995; Lemaitre et al. 2008) .
Genotyping and quality control
Of the 1033 participants recruited, 938 had high quality DNA samples (A260/280 >1.8, concentration >50ng/µl). Genotyping was performed using Illumina HumanCoreExome BeadChip, consisting of ≈240,000 tag single nucleotide polymorphisms (SNPs) and ≈240,000 exome variants, including loss of function variants and indels (https://support.illumina.com/array/array_kits/humancore_exome_beadchip_kit.html).
Standard quality control (QC) procedures were applied to filter variants and individuals using Plink 1.90 (https://www.cog-genomics.org/plink2) (Chang et al. 2015) . We removed variants with genotyping rate <90%, Mendelian error rate >10%, and significant deviation from Hardy-Weinberg equilibrium (P<10 −6 ). We removed individual samples with genotyping rate <95%, unresolved gender mismatch, autosomal heterozygosity >5%, and Mendelian error rate >5%.
We confirmed the reported familial relationships using identical-by-descent (IBD) segments (see below). The concordance across 22 DNA duplicates was 99.93%-99.96%, and the sample with the lower call rate for each pair was excluded. We calculated runs of homozygosity (ROH) using plink (--homozyg-kb 5000). A total of 901 individuals and 323,708 variants (281,586 variants with minor allele frequency (MAF) > 1%) passed QC and were used in downstream analyses.
Principal Component Analysis
Principal component analysis (PCA) was performed using the PC-AiR (Principal Components Analysis in Related Samples) method in the R GENESIS package (Conomos et al. 2016) , which is robust to known or cryptic relatedness. Our reference panel included West-Eurasian populations (covering Europe, the Middle East, and the Caucasus, n=922) (Behar et al. 2013) and the Jewish groups, listed in Supplementary Table 1 (n=174) (Behar et al. 2013 ). These samples served as the "unrelated subset" for running PC-AiR, and principal components (PC) values were then computed for the KFS individuals (the "related subset"). We also performed another analysis using only the Jewish groups (n=174) as the reference population, in order to focus on substructure within the Jewish ancestries. In that analysis, we also included a panel of AJ recruited in the United States for The Ashkenazi Genome Consortium (TAGC) (n=128) (Carmi et al. 2014) , which allowed us to examine differences in ancestry between AJ from Israel (KFS) and the United States. Another analysis was performed using only the AJ samples from Behar et al., 2013 (n=29) as the reference population, to focus on differences between Western and Eastern AJ.
Variants used in the PC-AiR analysis were restricted to MAF>1% and were pruned to eliminate linkage disequilibrium (LD), using the --indep-pairwise command in Plink (window size 50kb, variant count of 10 for shifting the window at the end of each step, and LD between variants
( 2 ) <0.1).
IBD Sharing and demographic reconstruction
The genotypes were phased using SHAPEIT2 v2 (O'Connell et al. 2014) . When SHAPEIT2 is run on family data, explicit family information is first ignored, and then a hidden Markov model (HMM) is applied (duoHMM) to correct switch errors in the inferred haplotypes according to parent-child relationships (O'Connell et al. 2014) . We detected pairwise shared haplotypes (IBD segments) in the cohort using GERMLINE (Gusev et al. 2009 ). The GERMLINE parameters were:
bits=40, err_hom=1, err_het=1, min_m=3 (centiMorgan, cM), hextend=0. The segments identified by GERMLINE are known to suffer from a high rate of false positives (Durand et al. 2014) . We thus filtered the segments using HaploScore (Durand et al. 2014) , which is a measure of the number of genotyping and phase switch errors required to explain each segment;
segments with a HaploScore >2.5 were removed. We also removed segments with more than 5% overlap with sequence gaps (http://genome.ucsc.edu/), less than 16 variants per cM, or an overlap with the HLA region (chr6:24-37M). For the demographic analysis in the AJ samples, we retained only segments shared between Ashkenazi founders (n=303), as identified by the first PC in the PCA of Jewish populations (Results). An evaluation of the improvement in the accuracy of detected IBD segments due to the pedigree-based phasing is provided in Supplementary Note 1.
To estimate the demographic history of AJ using the IBD segments, we used a previously developed method ), which we have recently applied (Carmi et al. 2014; Zidan et al. 2015; Gilbert et al. 2017) . Briefly, we assumed a model of an ancestral (diploid) effective population size N A , then an instantaneous bottleneck, T B generations ago, with an effective population size N B , and finally an exponential expansion to a current population size N C (Zidan et al. 2015) . We divided the space of segment lengths between 3-30 cM into 25 intervals equally spaced in log-scale. For each interval, we computed the proportion of the genome, averaged over all each pairs of haplotypes, that falls within IBD segments with length in the specified interval. We used a grid search to infer the demographic parameters. For each parameter combination and for each interval, we computed the expected proportion of the genome in IBD segments using a previously developed theory ) (see also (Zidan et al. 2015) ). The fit of each model was evaluated as the sum, over all intervals, of the square of the log-ratio of the actual (AJ) and theoretical proportions. The fitting error was plotted for each parameter separately, by fixing the value of the given parameter and optimizing the model over the other three parameters.
Imputation
After pre-phasing the microarray genotyped data using SHAPEIT2, imputation was performed in chunks of length 5MB each, using IMPUTE2 (Howie et al. 2012) . For the reference panel, we used either an Ashkenazi-only reference panel (TAGC; n=128) (Carmi et al. 2014) , the 1000
Genomes reference panel phase 1 version 3 (n=1092), or the combined Ashkenazi + 1000
Genomes panel (n=1220). We ensured strand consistency of the array genotypes compared to the sequence data. To compare the imputation accuracy between the three reference panels, we used the estimates provided by IMPUTE2, as the concordance between true array genotypes and their imputed value when masked. The concordance was highest when the imputation was performed using the combined reference panel. Therefore, we used the combined panel for our association analyses. Imputed genotypes were available at 82,328,870 variants; however, for most analyses we only considered 6,858,900 variants with MAF ≥ 1%
(calculated in founders only) and imputation quality score ≥0.9.
Enrichment Analysis and Functional Annotation
In populations that are genetically isolated or have undergone recent strong genetic drift such as Ashkenazi Jews Carmi et al. 2014) , it is expected that some risk variants of large effects may rise in frequency compared to the general population, resulting in an increased power to detect an association (Hatzikotoulas et al. 2014) . We thus focused on variants with a substantially higher frequency in the founder population (in our case, the KFS participants) compared to the general population, which we take as the non-Finnish Europeans (NFE) population from The Genome Aggregation Database (gnomAD). We observed that a naïve search for variants with a large frequency difference between the KFS and Europeans led to numerous artifacts. We thus implemented a series of QC steps. First, we filtered variants for which the KFS MAF (founders only, n=393) differed by >10% from the AJ MAF in gnomAD (Lek et al. 2016) . Similarly, we filtered variants with >10% MAF difference between the NFE population from the 1000 Genomes Project phase 3 (CEU + GBR + TSI + IBS; n=404) (Auton et al. 2015 ) and gnomAD (n≈7500) (Lek et al. 2016) . Lastly, we focused on variants that are very rare (MAF<0.1%) in the gnomAD NFE population and relatively common (MAF≥1%) in the KFS cohort, resulting in n= 212,505 "enriched" variants.
To determine if the MAF ratio correlates with functional consequences of the enriched variants, we annotated them using the SnpEff version 4.3q (Cingolani et al. 2012) . Variants that were present in the KFS but missing in the gnomAD NFE population (i.e. "infinite-fold" enriched) were excluded from the functional annotation. On a subset of variants with >100x KFS/NFE frequency ratio and high/moderate predicted functional impact, we also performed gene-set enrichment analysis (GSEA) using the Molecular Signatures Database (MSigDB, Subramanian et al., 2005) .
Association analysis
Association tests were carried out in BOLT-LMM v2.2 (Loh et al. 2015b ). BOLT-LMM uses a linear mixed model approach, which accounts for relationships between individuals and population structure, as well as handles the imputed 'dosage' data. For building the mixed model, we used 299,509 genotyped variants (MAF>0.1%). We used the 1000 Genomes LD-Score Supplementary Table 3 lists the 16 anthropometric and cardiometabolic traits we analyzed and their corresponding heritability estimates (based on all imputed genetic variants), as calculated by BOLT-REML (Loh et al. 2015a ). In case a phenotype was measured in both phases, we used the value from the most recent phase. All association models used age, gender, and phase as covariates. Lipid-lowering medication was accounted for in analyses of lipid traits by introducing a dichotomous covariate for medication use (yes/no). We adjusted for bloodpressure-lowering medication by adding 10 and 5 mmHg to systolic (SBP) and diastolic (DBP) blood pressures, respectively (Cui et al. 2003) . Lipoprotein (a), C-reactive protein, and triglycerides variables were inverse normal transformed because of their skewed distributions.
We observed no improvement in association results when using the non-infinitesimal mixed model test in BOLT-LMM, and thus all reported results are for the standard infinitesimal model.
Results
Samples
Our study included 1033 participants (47% male, 53% female), recruited during two phases (1992-1993 and 1999-2000) from 150 families (445 founders; 43%); see Methods for details.
The mean number of generations per family was 2.63 (range 1-4), with the majority of families spanning 3 (57.3%) and 2 (28.0%) generations. The mean family size was 6.89 individuals (range 2-55).
Participants' characteristics by gender are given in 
Population genetics
Principal Component Analysis (PCA)
To study the genetic ancestry of the KFS participants, we ran PCA (Methods) on the genotyped KFS samples (n=901), along with worldwide (n=922) and Jewish (n=174) reference populations (Behar et al. 2013 ) ( Supplementary Table 1 ). The first two principal components ( Next, we sought to determine whether the genetic ancestry of AJ with recent origins in Eastern
Europe differs from those with recent origins in Western Europe. We designated KFS individuals born in Germany as Western AJ, and individuals born in Poland, Russia, Hungary, and Romania as Eastern AJ. A PCA plot revealed that Eastern and Western AJ can be distinguished in PC space, albeit imperfectly (Figure 4 ). Specifically, while many Western AJ clustered separately from Eastern AJ, some were indistinguishable from them. We observed the same pattern in the samples of (Behar et al. 2013 ).
We also sought to determine whether there are differences between the genetic ancestry of Israel-based and US-based AJ. To this end, we compared the (Israeli) KFS samples to a cohort of 128 US-based AJ who were recently whole-genome sequenced (Carmi et al. 2014) . A PCA plot of the two groups, along with the Ashkenazi reference samples from Behar et al., 2013 ( Figures   3 and 4) , did not show any difference in the ancestry of Israel-and US-based AJ.
IBD Sharing and demographic reconstruction
To study sharing of identical-by-descent (IBD) haplotypes in the KFS study samples, we phased the genomes using SHAPEIT (with explicit modeling of parent-child relationships), and detected pairwise IBD segments longer than 3cM using Germline (Methods). The mean number of segments shared between a pair of unrelated KFS individuals (n=392 founders) was 4.19, with a mean segment length of 4.16cM.
It was previously shown that the number and lengths of IBD segments can be used to estimate the parameters of the founder event experienced by AJ Carmi et al. 2014) . The time of the founder event was estimated as ≈25-35 generations ago, and the effective population size (the "bottleneck size") as ≈300-400 individuals. We sought to determine whether these conclusions hold for our KFS AJ cohort, in particular that our study is family-based, which is expected to improve the accuracy of phasing and thereby IBD sharing detection (Methods).
Focusing on Ashkenazi founders (n=303; PC1 ≤ 0), we followed the method of ). We computed the proportion of the genome in IBD segments in each of a number of length intervals, and used the theory developed in ) and a grid search to find the best fitting demographic model ( Supplementary Figure 2 and Methods). We limited ourselves to models with a constant ancestral size followed by a sudden reduction in the effective population size (a bottleneck) and an exponential expansion until the present ( Supplementary Figure 3) . The fitting errors for each model parameter are plotted in Supplementary Figure 4 .
The inferred time of the founder event was 23 generations ago, which roughly corresponds to ≈600-700 years ago, slightly more recent than previous studies. The 95% confidence interval, using 100 bootstrap iterations over the chromosomes, was [22, 24] . The inferred bottleneck size was 450 (diploid) individuals (bootstrap 95% confidence interval: [375, 475] ). This is slightly higher than in previous studies (≈1.5x), but still represents a severe bottleneck. The growth rate was estimated as 42% per generation (current effective size ≈1.7M, 95% interval: [0.4,2.6]M).
The inferred ancestral population size was large (>10 5 , Supplementary Figure 4A ), though we could not obtain a precise estimate, since the best fit was always on the upper boundary of the grid. This is likely due to the relatively little sharing of short IBD segments (≈3-4cM; Supplementary Figure 3 ) and the lack of information on even shorter segments (<3cM).
Incorporating more complex models, shorter segments, and/or sequencing data is expected to improve the accuracy of the inferred parameters and resolve the population size history also between the bottleneck and ≈200 generations ago Browning and Browning 2015) .
IBD sharing can also reveal differences in ancestry between Eastern and Western AJ. The mean number of segments shared within Western AJ was 1.4x larger than within Eastern AJ (8.4 vs 5.9, P<10 -7 ; Table 2 ), but the mean segment length was similar (≈5.5cM, P=0.28). Sharing levels were particularly high in the group of Western AJ that was distinct in the PCA plot ( Table 2 ). The number and lengths of runs of homozygosity (length >5Mbp; Methods) did not significantly differ between Eastern and Western AJ (2.18 vs. 2.21 segments with mean lengths 9.7 vs.
8.4Mbp, respectively; P>0.05 for both comparisons; Table 3 ).
Functional Annotation of variants enriched in the KFS compared to Europeans
We annotated the function of 212,505 variants of minor allele frequency (MAF) > 1% in the KFS and with >10x MAF ratio between the KFS and Europeans (Methods). We identified 62 (0.03%) high impact and 291 (0.13%) moderate impact variants, with the remaining variants predicted to have low or no functional significance ("modifiers") according to SnpEff ( Supplementary   Table 5 ). We observed no correlation between MAF enrichment in the KFS population and the putative functional significance (Supplementary Figure 5) .
Gene-set enrichment analysis (GSEA) on 85 genes with >100x enriched variants and high/moderate functional impact (Methods) identified significant enrichment (false discovery rate q-value <0.01) within 32 gene sets (pathways) in the molecular signature database (MSigDB) in GSEA. The top pathways enriched for genes with AJ-specific variants were largely involved in cancers (breast cancer, pancreatic cancer, melanoma, and leukemia, among others).
GSEA for >10x enriched variants with high or moderate functional significance returned similar pathways (not shown). There was no enrichment for cancer-related pathways when random sets of genes with variants of no functional significance were analyzed.
Association of variants enriched in the KFS with anthropometric and cardiometabolic traits
We considered only the 212,505 variants enriched with >10x higher frequency in the KFS compared to Europeans, and used BOLT-LMM to test for an association with each of 16 anthropometric and cardiometabolic traits (Methods; qq-plots are shown in Supplementary   Figure 6 ). Due to the relatively small number of variants tested, the P-value threshold for genome-wide significance was 1.61•10 -6 (Methods). At this significance level, 24 variants demonstrated significant associations (Table 4 ).
Our main findings include a region spanning seven variants (453kb, MAF enrichment between 56 and 228), located in chr8p23.1, and associated with body weight, waist circumference, and body mass index (BMI). The most significant association was observed with body weight for (hg19) chr8:9887880:G>T (P = 3.6•10 -8 ), an imputed variant located upstream of the MSRA (methionine sulfoxide reductase A) gene. This is the only variant with study-wide significant association (P<1.61•10 -6 /16), and it was also associated with waist circumference (P=1.2•10 -7 )
and BMI (P=1.1•10 -6 ). We replicated this finding in another Israeli cohort, the Jerusalem Perinatal Study (JPS), which we described in (Lawrence et al. 2015) , and which consists mainly of parents and their children who were born in the 1970s in Jerusalem. Applying the same methodology as used here (a linear mixed model with adjusting for age and sex), chr8:9887880:G>T showed a nominally significant association in the JPS with weight (P=0.003, n=1291), BMI (P=0.035, n=1288), and waist circumference (P=0.038, n=448).
Another large region (1.9Mb) in chr13q14.3 showed a significant association with lipoprotein(a) (LPA). The region contained ten variants, all with >189-fold higher MAF between KFS and NFE, with the most significant result at rs780360029:C>T (P = 3.8•10 -7 ). These variants span eight genes (Table 4) , three of which belong to a region that is frequently deleted in B-cell chronic lymphocytic leukemia (called DLEU) (Rowntree et al. 2002) . Two intronic variants in chr6q25.3-26 were associated with LPA; rs754054303 located in the ACAT2 gene and rs185882981 located in the LPA gene (Table 4) . Two additional intronic variants in chr17q25.1 -rs566833653 in CDR2L and rs759145164 in KCTD2 -were both associated with height (P =
Discussion
We analyzed the genotypes of 901 individuals from extended families living in Kibbutzim in Israel, who participated in a longitudinal study with detailed records of anthropometric traits and cardiometabolic factors. The data enabled us to refine population genetic patterns of Israeli Jews, as well as study genetic associations with 16 traits.
Ashkenazi Jewish population genetics
A PCA analysis confirmed self-reported ancestries (whenever available) and allowed precise assignment of ethnic origins for most individuals. Participants in this cohort were mostly of AJ origin (81.4%), with the remaining having various other Jewish ancestries. Present-day AJ descend from Jewish ancestors who lived in Eastern and (most of) Western Europe. One theory of Ashkenazi origins is an initial settlement in Western Europe (Northern France and Germany), and later migration and expansion in Poland and the rest of Eastern Europe (Weinryb 1972 ). An open question is whether the genetic ancestry of AJ with origins in Eastern Europe differs from those with recent origins in Western Europe. A previous study of ≈1300 AJ (Guha et al. 2012) did not find a correlation (on a PCA plot) between genetic ancestry and a country of origin. A later study of 29 AJ (Behar et al. 2013) , which is part of the Jewish reference panel used here, did not identify genetic differences between Eastern and Western AJ, except for a minute East-Asian component in the ADMXITURE analysis that was present in Eastern, but not Western AJ.
Our analysis of the KFS individuals who reported their country of origin showed that many Western AJ cluster separately from Eastern AJ, and the same pattern was observed in our reanalysis of the samples of (Behar et al. 2013) . IBD sharing analysis showed, on average, 1.43x more shared segments within Western AJ compared to Eastern AJ, and an even higher levels of sharing (2.11x) for those Western AJ who were distinct on PCA (Table 2 ; Figure 4) . These results suggest that at least some Western AJ descend from a slightly smaller subset of the founders compared to Eastern AJ (Table 2 ). An explanation consistent with these observations is that
Western AJ consist of two slightly distinct groups: one that descends from a subset of the original founders (represented by those who are distinct on the PCA plot), and another that has migrated there back from Eastern Europe, possibly after receiving a limited degree of gene flow.
Following the large-scale migrations of the 20th century, present-day AJ live mostly in the US and in Israel. We compared the KFS samples, which were collected in Israel, to genomes of USbased AJ (Carmi et al. 2014) . A PCA plot of the two groups (Figures 3 and 4 ) revealed no differences in the ancestry of Israel-based and US-based AJ. This result, which agrees with the IBD-based analysis of (Gusev et al. 2012) , is expected based on the short time since the migrations out of Europe and suggests that the source population for these migrations was relatively homogeneous.
Sharing of IBD haplotypes between and within populations can be highly informative on recent demographic events (e.g., Ralph and Coop 2013; Browning and Browning 2015; Zidan et al. 2015) ). It was previously estimated that AJ have experienced a founder event ≈25-35 generations ago with an effective population size ( "bottleneck size") of ≈300-400 individuals Carmi et al. 2014) . We established that these conclusions hold for our independent AJ sample, which is particularly important since our study is family-based, and thus has higher accuracy of IBD sharing detection.
Analysis of enriched variants
Studying isolated and founder populations, such as the AJ population, is expected to increase power to discover disease-associated genes due to drift to relatively high frequencies of rare or unique risk alleles (Peltonen et al. 2000; Zeggini 2012; Hatzikotoulas et al. 2014) . Additionally, linkage disequilibrium in isolated populations tends to extend over longer distances resulting in longer haplotypes, thus empowering imputation approaches. Here, we did not observe correlation between variants enriched in AJ (the KFS) and their putative functional significance.
However, for functionally significant variants that are particularly enriched in AJ (>100x frequency ratio to Europeans), we identified a significant overlap with several cancer-related gene-sets (including breast cancer). AJ women have a much higher-than-average risk of breast cancer mostly due to a higher risk of having founder mutations in the BRCA1 and BRCA2 genes (Levy-Lahad et al. 1997) . While no MAF enrichment was observed in BRCA1 or BRCA2 genes in KFS, some genes with enriched variants were found to interact with BRCA1 ( Supplementary   Table 6 ). We note that whether cancer is more prevalent in Ashkenazi Jews compared to the general Western population is debated, and possibly limited to colorectal and pancreatic cancers, if at all (Feldman 2001; Lynch et al. 2004; Streicher et al. 2017) .
Overall, we observed 24 enriched variants in the KFS (compared to Europeans) that were associated with anthropometric and cardiometabolic traits. Regions of interest include seven variants located in chr8p23.1, surrounding the MSRA gene, which were associated with body weight, waist circumference, and BMI. The most significant variant, located in this region (chr8:9887880:G>T) was also replicated in another Israeli cohort, supporting our finding.
Variants relatively close to this region (100kb upstream), located between the genes TNKS and MSRA, have been previously shown to be associated with extreme obesity in children and adolescents (Scherag et al. 2010 ) and with adult waist circumference (Lindgren et al. 2009 ) in European ancestry. Our findings may implicate MSRA as a candidate gene for the observed associations. This gene encodes a ubiquitous and highly conserved protein that carries out the enzymatic reduction of methionine sulfoxide to methionine. Another region of interest is chr13q14.3, showing significant associations of 10 variants with LPA. This region includes the DLEU genes, which are frequently deleted in B-cell chronic lymphocytic leukemia, suggesting a role of one or more tumor suppressors (Rowntree et al. 2002) . The variant rs749307626 is located in an intronic region of the DLEU2 gene, which was previously associated with waist-tohip ratio in a meta-analysis of African and European populations (Ng et al. 2017) . Three variants are located in the DLEU1 gene, previously associated with anthropometric traits in another isolate; Korčula Island, Croatia (Polasek et al. 2009 ). One variant is located in the DLEU7 gene, previously associated with height in Europeans and Africans (Kang et al. 2010) . The variant rs756877701 is located in an intronic region of the PHF11 gene, which was previously associated with cardiomegaly in the Amish population (Parsa et al. 2011) . Two intronic variants in chr6q25.3-26 that were associated with LPA are located in the known LPA locus (Ober et al. 2009; Kettunen et al. 2016) , providing evidence for the generalizability of our results. Other variants (non-enriched) in this region also showed highly significant associations with LPA in the KFS; the most significant association was seen for rs56393506:C>T, 1900bp upstream of LPA's
Future directions
We reported the first genome-wide association analysis (to our knowledge) of cardiometabolic traits in the Israeli Jewish population, and detected a number of suggestive associations. Our study also refined the understanding of the population genetics of Ashkenazi and other Jewish groups. Current limitations of our study include its relatively small sample size and its focus on Ashkenazi Jews. Thus, additional analyses will be required in larger Jewish samples, as well as in other populations, to replicate the findings and elucidate the role of the associated variants in the development of the phenotype.
We envision a number of ways in which our data could be used in future studies by researchers interested in the genetics of anthropometric and cardiometabolic traits, as well as in Jewish genetics. First, our cohort could be meta-analyzed along with larger cohorts, or could be used for the replication of signals found in other populations. Power to replicate associations in our cohort is expected to be relatively high, due to the Ashkenazi founder event (Carmi et al. 2014) and the relatively homogenous environment of the Kibbutzim. Second, our data could be used to improve the understanding of differences in the genetic architecture of the investigated traits between Jews and other populations. Similarly, our data could be used to compare and refine the genomic prediction accuracy across populations (Marquez-Luna et al. 2016; Coram et al. 2017) . Third, the family structure of our cohort and the presence of longitudinal phenotypic data will allow additional analyses, such as a GWAS on the longitudinal change and a search for parent of origin effects. Finally, our cohort could be utilized for studies of the population genetics of the Jewish people. While other cohorts exist (Atzmon et al. 2010; Guha et al. 2012; Behar et al. 2013) , our cohort is the largest to include extended families, it represents multiple Jewish ancestries, and it has (partial) information on the participants' countries of origin. For example, algorithms for identification of related individuals in a random sample are known to underperform in AJ, due to the abundance of IBD sharing even between unrelated individuals (Paull et al. 2014) . Our dataset could be used for the development of algorithms for pedigree reconstruction in AJ and other isolated populations. A1 is the minor allele and the effect allele. Effect sizes are in units of the phenotypes ( Supplementary Table 3 ). We used a genomewide significance threshold of P=1.61•10 -6 (Methods). The MAF in the KFS was computed in founders only. None of the variants was found in the 1000 Genomes NFE population. The most strongly associated variant, which is associated with BMI, weight, and waist circumference, is highlighted. Abbreviations: C.: circumference, WHR: waist to hip ratio, LPA: Lipoprotein(a)
